Bayer continues to form new partnerships to expand its targets for cancer treatment, recently collaborating with MOMA and ...

AI is evolving fast and life sciences is feeling the impact. In 2025, its role will expand even further, driving efficiencies ...

IMUNON announced that its new DNA-based immunotherapy for advanced ovarian cancer has shown encouraging results in the ...

New data for darolutamide confirm safety and improved efficacy across subgroups of patients with metastatic hormone-sensitive prostate cancer (mHSPC) by 40% and 70% respectively, compared to placebo ...